Home » Topics » BioWorld Science

BioWorld Science
RSS

Heat Biologics initiates first-in-human study of HS-130 with HS-110 in solid tumors

Oct. 28, 2019

Arcutis plans phase III program with ARQ-151 for plaque psoriasis

Oct. 28, 2019

Antimalarial agents detailed in UCB patent

Oct. 28, 2019

TaiMed Biologics discontinues development of TMB-607

Oct. 28, 2019

Y-mAbs announces presentation of data on naxitamab for neuroblastoma and osteosarcoma

Oct. 28, 2019

FUJIFILM synthesizes beta-lactams

Oct. 28, 2019

Merck & Co. presents new hSTING agonists

Oct. 28, 2019

Silverback Therapeutics discloses TGFR-1 inhibitors

Oct. 28, 2019

Betta Pharmaceuticals divulges new PD-1/PD-L1 interaction inhibitors

Oct. 28, 2019

Metastases, tumors, similar in broad view, different in detail

Oct. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.